North America Colorectal Cancer Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country

No. of Pages: 157
Report Code: TIPRE00009241
Category: Life Sciences
North America Colorectal Cancer Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. North America Colorectal Cancer Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. North America Colorectal Cancer Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. North America Colorectal Cancer Market Regional Analysis

6.2 North America Colorectal Cancer Market Revenue 2020-2028 (US$ Million)
6.3 North America Colorectal Cancer Market Forecast Analysis

7. North America Colorectal Cancer Market Analysis – by Modality

7.1 Diagnosis Type
  • 7.1.1 Overview
  • 7.1.2 Diagnosis Type: North America Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Therapy Type
  • 7.2.1 Overview
  • 7.2.2 Therapy Type: North America Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Imaging Type
  • 7.3.1 Overview
  • 7.3.2 Imaging Type: North America Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Colorectal Cancer Market Analysis – by End User

8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Hospitals: North America Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Diagnostic and Research Laboratories
  • 8.2.1 Overview
  • 8.2.2 Diagnostic and Research Laboratories: North America Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Colorectal Cancer Market – North America Analysis

9.1 Overview

9.2 North America
  • 9.2.1 North America Colorectal Cancer Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 9.2.1.1 North America Colorectal Cancer Market – Revenue and Forecast Analysis – by Country
  • 9.2.1.1 US: North America Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.1.1 US: North America Colorectal Cancer Market Breakdown, by Modality
    • 9.2.1.1.2 US: North America Colorectal Cancer Market Breakdown, by End User
  • 9.2.1.2 Canada: North America Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.2.1 Canada: North America Colorectal Cancer Market Breakdown, by Modality
    • 9.2.1.2.2 Canada: North America Colorectal Cancer Market Breakdown, by End User
  • 9.2.1.3 Mexico: North America Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.3.1 Mexico: North America Colorectal Cancer Market Breakdown, by Modality
    • 9.2.1.3.2 Mexico: North America Colorectal Cancer Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments

12. Company Profiles

12.1 Abbott
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Amgen Inc.
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Bruker Corporation
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Clinical Genomics Technologies Pty Ltd.
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Epigenomics AG
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 F. Hoffmann-La Roche AG
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Quest Diagnostics
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 VolitionRx Limited
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments

13. Appendix

13.1 About Business Market Insights
13.2 List of Abbreviations

The List of Companies - North America Colorectal Cancer Market

  • Abbott
  • Amgen Inc.
  • Bruker Corporation
  • Clinical Genomics Technologies Pty Ltd.
  • Epigenomics AG
  • F. Hoffmann-La Roche AG
  • Quest Diagnostics
  • VolitionRx Limited
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)